Skip to main content

Maria Mar Hernandez Guillamon

Senior Researcher, Neurovascular Research Lab, VHIR.

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Maria Mar Hernandez Guillamon

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Senior Researcher, Neurovascular Research Lab, VHIR.

Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.

Projects

Estrategias para mejorar la eficacia y seguridad del tratamiento con Simvastatina en la Fase Aguda del Ictus Isquémico: STARS trial

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Estevo Santamarina Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 175450
Reference: EC07/90195
Duration: 01/11/2007 - 30/06/2012

Estudio sobre las causas que originan diferencias de género en la enfermedad neurovascular ¿Es el Ictus una patología machista?

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 41910
Reference: MD07/00209
Duration: 01/01/2008 - 31/05/2009

European Stroke Research Network (EUSTROKE) Grant Agreement Nº 202213

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Maria Mar Hernandez Guillamon, Carlos Molina Cateriano, Anna Rosell Novel
Funding agency: EUROPEAN COMMISSION
Funding: 463200
Reference: EUSTROKE_FP7HEALTH2007
Duration: 01/03/2008 - 31/08/2013

Angiopatía amieloide cerebral (AAC)

IP: Joan Montaner Villalonga
Collaborators: Maria Mar Hernandez Guillamon
Funding agency: Instituto de Salud Carlos III
Funding: 148377.88
Reference: CD06/00028
Duration: 01/01/2007 - 31/12/2010

Related news

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Ana  Román Mora

Ana Román Mora

Secretary
Communication Unit
Communication Directorate
Read more
Laura Palau Triola

Laura Palau Triola

Research technician
Rheumatology
Read more
Silvia Ruiz Álvarez

Silvia Ruiz Álvarez

Administration and Management
Neurovascular Diseases
Read more
Andreu Fernández Codina

Andreu Fernández Codina

Postdoctoral researcher
Rheumatology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.